Media

All news HealthCap news Interviews

Strongbridge Biopharma plc Announces Top-Line Results from Extended Evaluation Phase of the Pivotal Phase 3 SONICS Study of RECORLEV™ (levoketoconazole) for the Potential Treatment of Endogenous Cushing’s Syndrome

Modus Therapeutics strengthens management team with appointment of Mats Blom, MBA as CFO

Strongbridge Biopharma plc Announces Upcoming Presentation of New Data from Phase 3 SONICS Study of RECORLEV™ (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome at the 2019 Annual Meeting of the Endocrine Society (ENDO)

Fusion Pharmaceuticals Announces Appointment Of John J. Crowley As Chief Financial Officer

February 27, 2019

Aprea Therapeutics Adds New Investor to Series C Financing

February 27, 2019

BONESUPPORT HOLDING AB (publ) – Full Year Report 2018

February 27, 2019

Nordic Nanovector ASA – Results for the Fourth Quarter and Full Year 2018

February 27, 2019

Data from Oncopeptides Clinical Trials HORIZON and ANCHOR Evaluating Melflufen in RRMM Selected for Presentation at the AACR Annual Meeting

February 26, 2019

Strongbridge Biopharma plc Reports Fourth Quarter and Full-Year 2018 Financial Results

February 25, 2019

GenSight Biologics completes a capital increase of €8 million without discount subscribed entirely by Sofinnova